Tirzepatide produced greater A1c reductions than semaglutide in the SURPASS-2 head-to-head trial, making it the stronger option for glycemic control
The results, in aggregate, support that treating both OSA as well as obesity may be the optimal treatment, with the awareness and acknowledgment that weight reduction in and of itself mitigates OSA
Remember, youve got this
Stomach: Discussion The point of this study is to investigate how flunixin meglumine therapy and its combination with alpha-lipoic acid can protect the liver and stomach in male rats used in experiments
Avoid areas where the skin is red, irritated, bruised, burned, hardened, scarred, or has lumps or stretch marks
In Italia, luso corretto del farmaco deve sempre rispettare le indicazioni del medico, il foglio illustrativo e le regole di AIFA, Ministero della Salute ed EMA